ライフサイエンスコーパス: infant formula

1 foods and beverages other than human milk or infant formula).

2 re infant death, and the costs of purchasing infant formula.

3 below the FDA's tolerance level of 1 ppm in infant formula.

4 to predict calcium content in ready-to-feed infant formula.

5 ted formula, and an unopened can of powdered infant formula.

6 roducts, legumes, offal, fish, and fortified infant formula.

7 n recovered from an unopened can of powdered infant formula.

8 d LNnT are among the HMOs now being added to infant formula.

9 milk, and 4744 (31%) were only or mostly fed infant formula.

10 with a specifically designed control (CTRL) infant formula.

11 well absorbed from breast milk compared with infant formula.

12 ally important in infants fed iron-fortified infant formula.

13 high, whereas it is lower from cow milk and infant formula.

14 lead to their widespread incorporation into infant formula.

15 alitative studies or those on advertising of infant formula.

16 eir potential use as an active ingredient in infant formula.

17 to 1.4-60 ng/mL and 4.4-182 ng/mL in liquid infant formula.

18 analysis of whole, skimmed, semi-skimmed and infant formula.

19 mmunomodulatory ingredients in foods besides infant formula.

20 eed crops might provide a source of HMFS for infant formula.

21 lly to human milk compared to bovine milk or infant formula.

22 lobule membranes (MFGM) during production of infant formula.

23 red to 150 mug/ml in bovine milk and none in infant formula.

24 ion (GID) of six sterilised model systems of infant formula.

25 of lactose-free foods including lactose-free infant formula.

26 was applied to the digestion of a commercial infant formula.

27 the quantification of soymilk in adulterated infant formula.

28 aneously into young germ-free mice fed human infant formula.

29 bules and processed submicronic emulsions in infant formulas.

30 ssary for newborn growth in maternal milk or infant formulas.

31 are an interesting alternative to cow's milk infant formulas.

32 be used to design the optimal composition of infant formulas.

33 pplied to determine melamine in cow milk and infant formulas.

34 eeds to be considered in the modification of infant formulas.

35 o that of lactose-containing, cow-milk-based infant formulas.

36 hts the issues related to the composition of infant formulas.

37 dd long-chain polyunsaturated fatty acids to infant formulas.

38 h other carbohydrate sources for specialized infant formulas.

39 l of lactoferrin, perhaps as a supplement in infant formulas.

40 ir glucoside conjugates in various soy-based infant formulas.

41 human or bovine milk or bovine milk-derived infant formulas.

42 ipid that is widely used as an ingredient in infant formulas.

43 S) was developed to extract tetracyclines in infant formulas.

44 erm cognitive benefit compared with standard infant formulas.

45 ul tool to help with development of improved infant formulas.

46 which is desired in heart-healthy foods and infant formulas.

47 mixtures of ascorbic acid and in commercial infant formulas.

48 proximately 3- to 4-fold above the untreated infant formulas.

49 randomly assigned to receive iron-fortified infant formula (465 mg Ca and 317 mg P/L) or the same fo

50 ed to receive iron-fortified, cow milk-based infant formula (465 mg Ca and 317 mg P/L) or the same fo

51 eemed (>=70% redemption rate) WIC foods were infant formula (86.0%), fruits and vegetables (69.6%), e

52 The results for fortified infant formula, a certified reference material (NIST 186

53 include a full breastfeeding package with no infant formula, a partial breastfeeding package with som

54 llion to $2416.5 million, where the costs of infant formula accounted for 11-38% of total costs.

55 lactose (2'FL), a prevalent HMO and a common infant formula additive, by establishing individualized

56 er calcium and phosphorus supplementation of infant formula affects the iron status of healthy full-t

57 8.2 to 9.2 log10 CFU; the placebo was dilute infant formula alone.

58 Infant formulas also contained choline and choline-conta

59 changes in WIC food-package assignments and infant formula amounts but no change in breastfeeding in

60 outcomes: WIC food-package assignments, WIC infant formula amounts, and breastfeeding initiation.

61 y for the analysis of vitamin B9 (folate) in infant formula and adult/pediatric nutritional products

62 rmula containing either lactose or CSS-based infant formula and compared with an equal number of excl

63 as observed between the use of ready to feed infant formula and enamel fluorosis.

64 d in the bioaccessible (soluble) fraction of infant formula and human milk are employed.

65 rapid and robust method for the analysis of infant formula and infant liquid milk samples.

66 on of <0.5 mug mL(-1) was determined in both infant formula and infant liquid milk.

67 Infant formula and orange juice samples were analyzed wi

68 e may be used for routine quality control of infant formula and other food ingredients containing pre

69 and, for comparison, in minimally processed infant formula and pasteurized bovine milk.

70 hypothesis that higher levels of protein in infant formula and the lack of human milk oligosaccharid

71 ree choline moiety is adequately provided by infant formulas and bovine milk, reevaluation of the con

72 change from cow' milk formula to hydrolyzed infant formulas and breast milk ahead of dairy products

73 After changing to hydrolyzed infant formulas and breast milk ahead of dairy products

74 re of high interest as active ingredients in infant formulas and dietary food supplements.

75 astfeeding and not an exclusive attribute of infant formulas and pasteurized bovine milk.

76 Current selenium contents of infant formulas and recommendations for dietary intakes

77 Use of soy-based infant formulas and soy/isoflavone supplements has arous

78 inc and copper absorption from several human infant formulas and the effect of phytate concentration

79 lly available 5'-mononucleotide supplemented infant formulas and three human breast milk samples were

80 a, a partial breastfeeding package with some infant formula, and a full formula package with a smalle

81 an additive in baked goods, dairy products, infant formula, and dietary supplements as a result of i

82 nistein and daidzein, two isoflavones in soy infant formula, and existing human studies of soy formul

83 on of MEL in different raw milk and powdered infant formula, and satisfactory results were obtained (

84 ethod was applied to detect tetracyclines in infant formulas, and the recoveries were obtained as 68.

85 preterm infants fed human milk compared with infant formula; and 2) to describe trends in the magnitu

86 Infant formulas are designed specifically to mimic the c

87 ilar to those in infants consuming soy-based infant formulas are infertile due in part to uterine imp

88 Infant formulas are introduced at later stages if human

89 Modifications to infant formulas are made when the preponderance of scien

90 Infant formulas are often supplemented to foster the dev

91 Infant formulas are supplemented with bifidobacteria or

92 Soy infant formulas are widely used, but few studies have ev

93 DHA supplementation of infant formula at 0.32% of total fatty acids improves vi

94 flavones and soyasaponins in seven soy-based infant formulas available in the Brazilian market to est

95 , and it may be a prospective substitute for infant formula base.

96 e support for addition of LCPUFA to standard infant formula but we are now doing further follow-up of

97 ciation and as a rationale for adding DHA to infant formula, but few long-term data support this poss

98 States-born infants, most of whom are issued infant formula by age 2 mo.

99 ated the level of H2O2 generated in the same infant formulas by approximately 3- to 4-fold above the

100 ured the absorption of calcium and zinc from infant formulas by using a multitracer, stable-isotope t

101 /kg), a constituent of human breast milk and infant formulas, by gavage, and plasma samples and brain

102 d use of essential fatty acid derivatives in infant formula can certainly be questioned on the basis

103 ifications occurring during sterilisation of infant formulas can affect protein digestibility and rel

104 Selenate fortification of infant formulas can improve the selenium status of prete

105 Concept infant formula (cIF, Nuturis(R)) mimics HM's fat globule

106 This novel concept of infant formula composition has given rise to concern and

107 these differences highlight that changes in infant formula composition impact infant metabolism, and

108 r infants with sufficient iron stores (e.g., infant formula consumers) are less clear.

109 ss index (BMI), number of breastfeeds a day, infant formula consumption, and energy from complementar

110 d by a native phospholipid membrane, whereas infant formulas contain small, protein-coated lipid drop

111 The infant formulas contained ascorbate radicals ranging fro

112 All infant formulas contained significantly less phosphochol

113 Infant formula containing GOS sustained high levels of b

114 non-selenium-fortified preterm and full-term infant formulas containing 0.12 and 0.11 mumol Se/L, res

115 ved selenate-fortified preterm and full-term infant formulas containing 0.36 and 0.22 mumol Se/L, res

116 omly assigned to be fed 1 of the following 4 infant formulas containing equivalent nutrient amounts,

117 al sources as older individuals, rather than infant formula contaminated during production.

118 has the potential to update many aspects of infant formula content and evaluation but will require a

119 ropean legal standards for protein amount in infant formula could be reduced with a potential reducti

120 chidonic acid (ARA) in human milk but not in infant formula, coupled with lower plasma and brain lipi

121 Three commercial infant formulas (denoted as P1, P2 and P3) were stored a

122 In infant formulas derived from soy or bovine milk, unester

123 rane matrix potentially opens the functional infant formula development pathway.

124 uman breast milk are important indicators of infant formula DHA and AA concentrations, and recent evi

125 aining HAAs) for the preparation of powdered infant formula did not remove them; therefore it would b

126 m infants receiving human milk compared with infant formula diets have a slower weight gain and head

127 endations for the mineral content of preterm infant formula differ greatly between committees.

128 trointestinal digestion system, for studying infant formula digestion, and to validate it by comparin

129 Understanding the mechanisms of infant formula disintegration in the infant gastrointest

130 This diet, ADM, contains milk protein, and infant formula, dissolved in a mixture of bovine red blo

131 LCP supplementation of term infant formula during the first year of life yields clea

132 idative properties of structured lipid-based infant formula emulsion containing dairy proteins, lacto

133 ssful incorporation of structured lipid into infant formula emulsion for better infant nutrition and

134 menhaden fish oil and structured lipid-based infant formula emulsion, were evaluated and compared.

135 Nowadays, a great number of infant formulas enriched with prebiotics are disposal in

136 its intended purpose in the highly regulated infant formula environment, including liquid formulation

137 More than 80% of the infant formulas examined had ratios of iron to copper ex

138 Additionally, infant formula exposure reduced the relative abundance o

139 Soy-based infant formula feeding and ultrasound-detected uterine f

140 able distributions of socioeconomic factors, infant formula feeding, and SSB consumption.

141 Socioeconomic status, infant formula feeding, and sugar-sweetened beverage (SS

142 regnancy, during the period of human milk or infant formula feeding, and through introduction of comp

143 ested in areas with water fluoridation), and infant formula feeds.

144 e (GML) in human milk versus bovine milk and infant formula for antimicrobial and anti-inflammatory a

145 with infant age, which may aid in developing infant formulas for different age stages.

146 er allowable limit of the protein content of infant formulas for the first year of life and limiting

147 The assay was used to screen four soy-based infant formulas, four corn-based cereals, corn tortilla

148 ree nationally prominent commercial powdered infant formulas generated hydrogen peroxide, ranging fro

149 breve BBG-001 suspended in dilute elemental infant formula given enterally in a daily dose of 8.2 to

150 ypothesis that nucleotide supplementation of infant formula has beneficial effects on fecal bacteriol

151 The chemical composition of infant formulas has been optimized but not the structure

152 a common contaminant of milk-based powdered infant formula, has been implicated as a causative agent

153 Bioactive ingredients for infant formula have been sought to reduce disparities in

154 f e-beam on chemical changes of nutrients in infant formula have not been determined.

155 ve antiretroviral prophylaxis, and access to infant formula have resulted in new perinatal infections

156 Soy-based infant formulas have been in use for >30 y.

157 ation of carbohydrates present in commercial infant formulas have been used.

158 Recent modifications in the fat blend of infant formulas have led to improved fat digestibility.

159 y-processed emulsion and two processed model infant formulas (homogenized or homogenized/pasteurized)

160 proximately two-thirds of US infants receive infant formula (IF) as a primary or sole nutritional sou

161 PLC-DAD in 20 commercial milk-based powdered infant formula (IF) brands from local markets from Paris

162 eir effect on physico-chemical properties of infant formula (IF) containing hydrolyzed and intact (no

163 ndirect (IN) UHT-treated experimental liquid infant formula (IF) during storage at 40 degrees C.

164 Protein modifications in liquid infant formula (IF) have been widely studied, but distin

165 for identification and quantification in an infant formula (IF) matrix: butyrophilin, mucin 1, xanth

166 Thermal treatment is a key step during infant formula (IF) processing which causes protein glyc

167 Compositional difference in infant formula (IF) tends to influence its functionality

168 eurized, and lactose-free UHT milk (ULF) and infant formula (IF) using tandem mass spectrometry (elec

169 pid oxidation of structured lipid (SL)-based infant formula (IF) was evaluated.

170 Foods, including human milk (HM) and infant formula (IF), can be sources of environmental con

171 l needs of infants and sets the standard for infant formula (IF).

172 sphatidylinositol (PI) species present in 32 infant formulas (IF) collected from Australia, Europe an

173 tra high temperature (UHT) treated milk, and infant formulas (IFs) after digesting the precipitated p

174 Since breastfeeding is not always possible, infant formulas (IFs) are supplemented with prebiotic ol

175 l that involved the adulteration of milk and infant formula in China that affected tens of thousands

176 fect of calcium- and phosphorus-supplemented infant formula in preventing lead absorption.

177 tween fluorosis on these enamel surfaces and infant formula in the form of powdered concentrate (OR=4

178 Thus, the use of soy-based infant formulas in the absence of medical necessity and

179 e will be more bioactive components added to infant formulas in the near future, but guidelines on ho

180 The vast majority of infant formulas in the United States contain the long-ch

181 An acute shortage of infant formulas in the United States occurred in early 2

182 rted interacting with the pharmaceutical and infant formula industries.

183 ally fluoridated children, born after the US infant formula industry voluntarily reduced the fluoride

184 grains, yogurt, infant formula, therapeutic infant formula, infant fruits and vegetables, infant cer

185 icine report on evaluating the safety of new infant formula ingredients and to recommend measurements

186 A or DHA when they are fed in combination as infant formula ingredients.

187 ons of exclusive human milk feeding prior to infant formula introduction, 4) feeding a lower versus h

188 Production of infant formulas involves high temperature processing for

189 ntary feeding (CF) starts when human milk or infant formula is complemented by other foods and bevera

190 s the process that starts when human milk or infant formula is complemented by other foods and bevera

191 metabolic fate of isoflavones from soy-based infant formula is described.

192 ility of adding their bovine counterparts to infant formula is discussed as well as the implications

193 The appropriate amount of protein to use in infant formula is still under discussion.

194 sideration when adding bioactive proteins to infant formula is that the total protein content of form

195 The higher protein content in infant formula is thought to contribute to the distinct

196 The choice of infant formula is thought to play an important role on g

197 Infant formula is usually made from bovine milk but milk

198 Absorption of calcium from a lactose-free infant formula is, however, adequate to meet the calcium

199 The required amount of iodine in infant formulas is based on caloric content, and the lab

200 Most of the fat currently used in infant formulas is obtained from plants, which exclude C

201 re for the determination of iron and zinc in infant formulas is presented.

202 quantitative significance of this effect in infant formulas is uncertain.

203 ly exposure of infants to isoflavones in soy infant-formulas is 6-11 fold higher on a bodyweight basi

204 sual measures used to assess the efficacy of infant formula LCPUFA supplementation are the electroret

205 s at age 4 mo in infants fed a lower-protein infant formula (LPF) or a lower-protein infant formula w

206 Nevertheless, feeding a "very-low" protein infant formula may cause limited protein synthesis durin

207 If so, varying the constituents of infant formula might be therapeutically advantageous.

208 hain polyunsaturated fatty acids (LCPUFA) to infant-formula milk during the first 6 months promotes l

209 domised controlled trials indicated that the infant formula modifications did not promote long term c

210 -month-old infants fed exclusively soy-based infant formula (n = 7), cow-milk formula (n = 7), or hum

211 MFGM supplementation to infant formula narrows the gap in cognitive development

212 effects of mineral concentrations in preterm infant formula on bone mineralization are lacking, recom

213 ied corn and rice starches (MCS, MRS)) to an infant formula on both in vitro mineral availability (Ca

214 The impact of probiotic-supplemented infant formula on the composition and function of the in

215 of nutritional intervention with hydrolysate infant formulas on allergic manifestations in high-risk

216 ght to investigate the effect of hydrolysate infant formulas on allergic phenotypes in children with

217 to take a comprehensive picture of powdered infant formulas on sale in Italy on the basis of their l

218 llent models in which to study the effect of infant formulas on trace element absorption and status.

219 ilk with formula or fortifier (mixed); or 3) infant formula only.

220 beta-rich lactose containing powders, e.g., infant formula or direct compression tablet formulations

221 infants either via drops or as contained in infant formula or foods.

222 sodium consumed comes from foods other than infant formula or human milk after the age of 6 mo.

223 Timing of introduction of solid foods, infant formula, or cow's milk was not related to risk of

224 Infants who were fed breast milk more than infant formula, or who were breastfed for longer periods

225 Three different infant formulas (P1, P2 and P3) were characterised, and

226 stigated to quantify calcium (Ca) content in infant formula powder (INF).

227 Thermal treatment during infant formula processing results in the generation of v

228 Infant formula products are predominantly manufactured u

229 Most infant formula products had at least one health and nutr

230 757 infant formula products were identified, each with a med

231 an typically found in human milk and current infant formula products, without the need to also includ

232 The "Follow-on formula" and "Infant formula" products contained the lowest average co

233 However, most of the infant formulas provide a methionine intake of 49-80 mg

234 Powdered infant formula purchase data from all major physical sto

235 e to characterize these dietary exposures in infant formula purchased in the US and to estimate the p

236 e tested whether the reduction of protein in infant formula reduces body mass index (BMI; in kg/m(2))

237 on of weaning food with either human milk or infant formula reduces the distinct characteristics of b

238 Data on breastfeeding, consumption of infant formula (regular, pre-/probiotics, partially hydr

239 ent to perform a comprehensive evaluation of infant formula regulation and safety in the United State

240 the stereoisomeric structure of palmitate in infant formula resulted in higher WBBMC, reduced stool s

241 The low sn-2 palmitate content of infant formulas results in formation of fatty acid calci

242 Comparative analysis with bovine milk and infant formula reveals significant elevations in permeab

243 PE-formula compared with that of a standard infant formula (S-formula) on arginine kinetics in criti

244 s of melamine (MEL) in raw milk and powdered infant formula samples by high performance liquid chroma

245 Soybean-based infant formulas (SBIFs) based on soybean protein isolate

246 ihypertensive peptides in five soybean-based infant formulas (SBIFs).

247 Commercially available infant formulas serve as the best alternative to human m

248 its for infants; however, when not feasible, infant formula serves as an alternative.

249 erimental designs to the question of whether infant formula should be supplemented with DHA.

250 esent recommendation that the composition of infant formulas should be based on the composition of hu

251 (MFGM) coated lipid droplets, while standard infant formula (sIF) and sIF with added MFGM (sIFM) cont

252 This study showed whey addition to infant formula significantly contributes to CML levels.

253 Lowering the protein content of infant formula so it is closer to that of mature breast

254 occasions during infancy as part of several infant formula studies, were contacted at age 20 to 32 y

255 of long-chain polyunsaturated fatty acids in infant formulas, the duration of exclusive breast-feedin

256 on (FDA) regulates the addition of iodine to infant formulas, the iodization of salt, and the additio

257 kfast cereal, bread or whole grains, yogurt, infant formula, therapeutic infant formula, infant fruit

258 Compared to bovine milk and infant formula, this study explores human breast milk's

259 The appropriate concentration of iron in infant formula to achieve iron sufficiency is more contr

260 sialylated oligosaccharides can be added to infant formula to enhance the oligosaccharide profile.

261 ormula effects could lead to modification of infant formula to improve immune function, reduce inflam

262 actooligosaccharides (GOS) that are added to infant formula to mimic the molecular sizes and prebioti

263 the ability of AA- and DHA(AA/DHA)-enriched infant formula to modulate immune responses in the neona

264 ity of human milk oligosaccharides (HMOs) in infant formula to sugar and fat replacers in dairy and b

265 n breast milk and can be added to milk-based infant formulas to support gut health and immunity.

266 rmed dissimilarities between bovine milk and infant formula triacylglycerol composition.

267 Likewise, we presented here a complete infant formula triacylglycerol profile and reported >200

268 At amounts of DHA in infant formula up to ~0.64%, AA contents should at least

269 Any breastfeeding and any infant formula use at 24 weeks post partum and time to b

270 ide supplements, fluoride toothpaste, and/or infant formula use in nonfluoridated communities.

271 (FRI classification II) enamel surfaces and infant formula use in the form of powdered concentrate (

272 ing, including probiotic supplementation and infant formula use, were monitored from birth using ques

273 method to determine the melamine in milk and infant formulas using 3-amino-5-mercapto-1,2,4-triazole

274 ly intake of MPs by children fed exclusively infant formula was estimated to be approximately 49 +/-

275 ingredients, its final concentration in the infant formula was insufficient to decrease in vitro min

276 Infant formula was not found to be associated with fluor

277 on of fresh milk products and cow milk-based infant formulas was related to the endpoint, whereas no

278 m the infant and from an opened container of infant formula were indistinguishable, while the PFGE pr

279 r brands of commercially available soy-based infant formulas were analysed, and the plasma concentrat

280 n is the main protein source for plant-based infant formula, whereas pea protein is considered as a p

281 in water and 100 parts per billion (ppb) in infant formula, which are well below the FDA's tolerance

282 ations were up to 10% of the counterparts in infant formula, while Nepsilon-carboxymethyllysine reach

283 y with a 7 h enrichment or 100 g of powdered infant formula with a 16 h enrichment.

284 Infant formula with a lower protein content reduces BMI

285 Whey-predominant infant formula with a lower protein content that more cl

286 Feeding an infant formula with a modified amino acid profile and a

287 We aimed to assess the safety of an infant formula with a modified amino acid profile and a

288 tein infant formula (LPF) or a lower-protein infant formula with additional active ingredients (probi

289 An infant formula with large, milk phospholipid-coated lipi

290 The contamination of Chinese infant formula with melamine caused urolithiasis and oth

291 Infant formula with MOS shifts the gut microbiota and me

292 to determine the degree of contamination of infant formula with MPs.

293 e was to test the hypothesis that feeding an infant formula with reduced energy and protein densities

294 e showed that a partially hydrolyzed protein infant formula with specific prebiotics modulated the gu

295 many studies have investigated the safety of infant formulas with reduced protein levels.

296 Treating infant formulas with the chelating agent diethylene tria

297 olysis trends were similar for both types of infant formulas, with long-chain fatty acid triglyceride

298 determine whether selenate fortification of infant formula would improve the selenium status of rela

299 erences in the composition of human milk and infant formula yield benefits in cognitive development a

300 demonstrated by quantitation of fluoride in infant formula, yielding recoveries of 86%-98% with repe